Regulation of gene expression with thyroid hormone in rats with myocardial infarction

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Chen, Yue Feng ^a   Pottala, James V ^b   Weltman, Nathan Y ^b   Ge, Xijin ^c   Savinova, Olga V ^b   Gerdes, A Martin ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c South Dakota State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RNA; THYROXINE; MUSCLE PROTEIN; THYROID HORMONE;

ABCC9 GENE; ADD3 GENE; ANGPT2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCKDHA GENE; BETAMHC GENE; BUB1 GENE; CARD9 GENE; COL8A1 GENE; CONTROLLED STUDY; CXCL12 GENE; FEMALE; FGF1 GENE; FUNCTIONAL MORPHOLOGY; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE FUNCTION; GNPDA2 GENE; GPX3 GENE; GSN GENE; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE REMODELING; HLA DMD GENE; HORMONE ACTION; IFI27L GENE; IRF7 GENE; IRF9 GENE; ISG12 GENE; ITGB3BP GENE; ITM2A GENE; KCNIP2 GENE; LIOTHYRONINE BLOOD LEVEL; LOC303407; LOC303407 GENE; LOC310926 GENE; LOC314472 GENE; LOC361646 GENE; LOC688103 GENE; MICROARRAY ANALYSIS; MRPL52 GENE; MX1 GENE; MYOC GENE; NFIX GENE; NONHUMAN; NPPA GENE; OAS1A GENE; OASL2 GENE; PAIP1 GENE; PFTK1 GENE; PLAG1 GENE; RALA GENE; RASA1 GENE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RGD1304646 GENE; RGD1311433 GENE; RGD1311874 GENE; RGD1559924 GENE; RGD1562052 GENE; RGD1564163 GENE; RGD735029 GENE; RNA ISOLATION; RT1 M6 2 GENE; RT1 N2 GENE; RT1 S3 GENE; SF3B3 GENE; SIGNAL DETECTION; SLC43A3 GENE; SPOCK2 GENE; SPRED1 GENE; THYROXINE BLOOD LEVEL; TMEM30A GENE; TMEM9B GENE; TNFSF5IP1 GENE; TREATMENT OUTCOME; TYKI GENE; WESTERN BLOTTING; YWHAQ GENE; ZFP36L1 GENE; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION PROFILING; METABOLISM; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; THYROID HORMONES; VENTRICULAR REMODELING;

EID: 84864758144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040161     Document Type: Article

References (42)

1. Pfeffer MA, Braunwald E, (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172.
2. Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, et al. (2000) Altered patterns of gene expression in response to myocardial infarction. Circ Res 86: 939-945.
3. Ojamaa K, Kenessey A, Shenoy R, Klein I, (2000) Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab 279: E1319-1324.
4. Chen YF, Kobayashi S, Chen J, Redetzke RA, Said S, et al. (2008) Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. J Mol Cell Cardiol 44: 180-187.
5. Pantos C, Mourouzis I, Markakis K, Tsagoulis N, Panagiotou M, et al. (2008) Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol 103: 308-318.
6. Henderson KK, Danzi S, Paul JT, Leya G, Klein I, et al. (2009) Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. Circ Heart Fail 2: 243-252.
7. Kalofoutis C, Mourouzis I, Galanopoulos G, Dimopoulos A, Perimenis P, et al. (2010) Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction. Mol Cell Biochem 345: 161-169.
8. Forini F, Lionetti V, Ardehali H, Pucci A, Cecchetti F, et al. (2011) Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats. J Cell Mol Med 15: 514-524.
9. Breisch EA, White FC, Hammond HK, Flynn S, Bloor CM, (1989) Myocardial characteristics of thyroxine stimulated hypertrophy. A structural and functional study. Basic Res Cardiol 84: 345-358.
10. Adamson C, Maitra N, Bahl J, Greer K, Klewer S, et al. (2004) Regulation of gene expression in cardiomyocytes by thyroid hormone and thyroid hormone analogs 3,5-diiodothyropropionic acid and CGS 23425 [N-[3,5-dimethyl-4-(4′-hydroxy-3′-isopropylphenoxy)-phenyl]-oxamic acid]. J Pharmacol Exp Ther 311: 164-171.
11. De K, Ghosh G, Datta M, Konar A, Bandyopadhyay J, et al. (2004) Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. J Endocrinol 182: 303-314.
12. Bertin J, Guo Y, Wang L, Srinivasula SM, Jacobson MD, et al. (2000) CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J Biol Chem. 275: 41082-41086.
13. Perkins ND, (1997) Achieving transcriptional specificity with NF-kappa B. Int J Biochem Cell Biol. 29: 1433-1448.
14. Misra A, Haudek SB, Knuefermann P, Vallejo JG, Chen ZJ, et al. (2003) Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 108: 3075-3078.
15. Sasaki H, Ray PS, Zhu L, Otani H, Asahara T, et al. (2001) Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF kappa B-dependent mechanism in a rat model of chronic myocardial infarction. J Mol Cell Cardiol 33: 283-294.
16. Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, et al. (2006) The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn 235: 3144-3155.
17. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
18. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
19. Sandhu R, Teichert-Kuliszewska K, Nag S, Proteau G, Robb MJ, et al. (2004) Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovasc Res 64: 115-124.
20. Tuo QH, Zeng H, Stinnett A, Yu H, Aschner JL, et al. (2008) Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 294: H2547-2557.
21. Liu GY, (2009) Isolation, sequence identification, and tissue expression profile of 3 novel porcine genes: NCF2, BCKDHB and BCKDHA. J Appl Genet 50: 47-50.
22. Matsuoka Y, Li X, Bennett V, (2000) Adducin: structure, function and regulation. Cell Mol Life Sci 57: 884-895.
23. Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, et al. (2010) The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 137: 1887-1896.
24. Kahaly GJ, Dillmann WH, (2005) Thyroid hormone action in the heart. Endocr Rev 26: 704-728.
25. van Rooij E, Olson EN, (2007) MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376.
26. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, et al. (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119: 2772-2786.
27. Ojamaa K, (2010) Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy. Vascul Pharmacol 52: 113-119.
28. Zimmer HG, Gerdes AM, Lortet S, Mall G, (1990) Changes in heart function and cardiac cell size in rats with chronic myocardial infarction. J Mol Cell Cardiol 22: 1231-1243.
29. Gerdes AM, Moore JA, Hines JM, Kirkland PA, Bishop SP, (1986) Regional differences in myocyte size in normal rat heart. Anat Rec 215: 420-426.
30. Pfeffer JM, Pfeffer MA, Braunwald E, (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57: 84-95.
31. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
32. Kuhn K, Baker SC, Chudin E, Lieu MH, Oeser S, et al. (2004) A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res 14: 2347-2356.
33. Lin SM, Du P, Huber W, Kibbe WA, (2008) Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 36: e11.
34. Du P, Kibbe WA, Lin SM, (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
35. Smyth GK, Michaud J, Scott HS, (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.
36. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
37. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
38. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371.
39. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
40. de Hoon MJ, Imoto S, Nolan J, Miyano S, (2004) Open source clustering software. Bioinformatics 20: 1453-1454.
41. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
42. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.